Noven Receives FDA Approval of a New Indication with a New Dose for Minivelle® (Estradiol Transdermal System) Minivelle now approved for prevention of postmenopausal osteoporosis at all doses Newmg day Minivelle, - substantial equivalence - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2014-09-24 14:42:18		Noven Receives FDA Approval of a New Indication with a New Dose for Minivelle® (Estradiol Transdermal System) Minivelle now approved for prevention of postmenopausal osteoporosis at all doses Newmg/day Minivelle, Add to Reading List Source URL: www.noven.com Download Document from Source Website File Size: 216,25 KB Share Document on Facebook